Virtual Reality for Delirium After Surgery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how virtual reality (VR) can help prevent delirium in older adults after surgery. Researchers compare traditional methods to a VR software called ReCognitionVR to determine which is more effective. They seek participants aged 60 or older, scheduled for certain abdominal surgeries, such as bowel or gallbladder surgery, without cognitive impairments or psychiatric disorders. The goal is to assess whether VR is a safe and acceptable way to support recovery and to inform future studies for critically ill patients. As an unphased trial, this study allows participants to contribute to innovative research that could shape future healthcare solutions.
Do I need to stop my current medications for this trial?
The trial does not specify if you need to stop taking your current medications. However, if you are being treated with medications for active psychiatric disorders, you may not be eligible to participate.
What prior data suggests that ReCognitionVR is safe for older surgical patients?
Research shows that virtual reality (VR) treatments like ReCognitionVR are generally safe for older adults. Studies have found that VR-based mental exercises are easy to manage. These exercises can help reduce stress, pain, and anxiety, which often occur after surgery.
In trials, participants using ReCognitionVR did not report any serious side effects. Although researchers continue to study VR technology, it appears to be a promising and safe option for older adults. This safety information may ease concerns for those considering joining a trial.12345Why are researchers excited about this trial?
Researchers are excited about the use of ReCognitionVR for treating delirium after surgery because it offers a novel approach through virtual reality. Unlike traditional orientation methods, which rely on standard cognitive exercises, ReCognitionVR immerses patients in a virtual environment to enhance cognitive engagement and recovery. This innovative delivery method has the potential to make therapy more interactive and enjoyable, possibly leading to better patient outcomes and faster recovery times.
What evidence suggests that ReCognitionVR is effective for delirium after surgery?
This trial will compare the use of virtual reality software, ReCognitionVR, with traditional orientation methods for reducing delirium after surgery. Research has shown that virtual reality (VR) tools like ReCognitionVR might help reduce post-surgery confusion, though the effect is small. One study found that immersive VR can significantly decrease confusion upon waking from anesthesia compared to other methods. ReCognitionVR is designed to offer mental exercises that might prevent confusion in at-risk patients. While it may not improve short-term memory or cognitive issues, it could alter how patients perceive pain after surgery. These early results suggest potential benefits, but further research is needed to confirm its effectiveness.678910
Who Is on the Research Team?
Hina Faisal, MD
Principal Investigator
The Methodist Hospital Research Institute
Are You a Good Fit for This Trial?
This trial is for older patients who have recently undergone surgery and are at risk of developing delirium, a state of confusion. Participants must be able to give consent and follow study procedures. Those with conditions that may interfere with the use of virtual reality or increase risks, such as severe visual impairment or motion sickness, cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive cognitive exercises using either traditional orientation methods or ReCognitionVR virtual reality software
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessment of treatment-emergent adverse events
What Are the Treatments Tested in This Trial?
Interventions
- ReCognitionVR
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Methodist Hospital Research Institute
Lead Sponsor
National Institute on Aging (NIA)
Collaborator